Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats: Evaluation of various kidney-related parameters

Indian Journal of Experimental Biology

Volumn 50, Issue 2, 2012, Pages 133-140

  Kiran, G ^a   Nandini, C D ^a   Ramesh, H P ^a   Salimath, P V ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Diabetes; Diabetic nephropathy; Glycosaminoglycans; Microalbuminuria; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; GLYCOSAMINOGLYCAN;

ALBUMINURIA; ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; MALE; ORGAN SIZE; PATHOLOGY; RAT; SECRETION (PROCESS); STATISTICAL MODEL; WISTAR RAT;

ALBUMINURIA; ANIMALS; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GLYCOSAMINOGLYCANS; KIDNEY; LINEAR MODELS; MALE; ORGAN SIZE; RATS; RATS, WISTAR;

RATTUS;

EID: 84857001990     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schena FP & Gesualdo L, Pathogenetic mechanisms of diabetic nephropathy, J Am Soc Nephrol, 16 (2005) S30.
2. Yoh K, Hirayama A, Ishizaki K, Yamada A, Takeuchi M, Yamagishi S, Morito N, Ojima M, Shimohata H, Itoh K, Takahashi S & Yamamoto M, Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice, Genes Cells, 13 (2008) 1159.
3. Kenneth K W & Youming H, Streptozotocin induced diabetic models in mice and rats, Curr Protoc Pharmacol, 40 (2008) 5.47.1.
4. Lewis E J & Xu X, Abnormal glomerular permeability characteristics in diabetic nephropathy: Implications for the therapeutic use of low-molecular weight heparin, Diabetes Care, 31 (2008) S202.
5. Schaeffer V, Hansen K M, Morris D R & Abrass CK, Reductions in laminin β2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose, Am J Physiol Renal Physiol, 298 (2010) F314.
6. Yozai K, Shikata K, Sasaki M, Tone A, Ohga S, Usui H, Okada S, Wada J, Nagase R, Ogawa D, Shikata Y & Makino H, Methotrexate prevents renal injury in experimental diabetic rats via anti inflammatory actions, J Am Soc Nephrol, 16 (2005) 3326.
7. Seon Y D, Lee T H & Lee M C, Changes of glomerular basement membrane components in vacor-induced diabetic nephropathy, Korean J Intern Med, 14 (1999) 7.
8. Bieri J G, Stoewsand G S, Briggs G M, Phillips R W, Woolard J C & Knapka J J, Report of the American Institute of Nutrition Ad Hoc committee on standards for nutritional studies, J Nutr, 107 (1977) 1340.
9. Hatch G M, Cao S G & Angel A, Decrease in cardiac phosphatidyl glycerol in streptozotocin induced diabetic rats does not affect cardiolipin biosynthesis: Evidence for distant pools of phosphatidyl glycerol in the heart, Biochem J, 306 (1995) 759.
10. Scott J E, Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues, Methods Biochem Anal, 8 (1960) 145.
11. Chandrashekhar S, Esterman M A & Hoffman M A, Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride, Anal Biochem, 161 (1987) 103.
12. Zheng S, Noonan W T, Metreveli N S, Coventry S & Kralik P M, Development of late-stage diabetic nephropathy in OVE26 diabetic mice, Diabetes, 53 (2004) 3248.
13. Weibel E R, Stereological methods, Practical methods for biological morphometry, (Academic Press, London) 1979, 51.
14. Hugget A S G & Nixon D A, Use of glucose oxidase, peroxidase and o-dianisidine in the determination of blood glucose and urinary glucose, Lancet, 273 (1957) 366.
15. Miller G L, Use of Dinitrosalicylic acid reagent for determination of reducing sugar, Anal Chem, 31 (1959) 426.
16. Folin O & Wu H, A system of blood analysis, J Biol Chem, 38 (1919) 81.
17. Yokozawa T, Chung H Y, He L Q & Oura H, Effectiveness of green tea tannin on rats with chronic renal failure, Biosci Biotechnol Biochem, 60 (1996) 1000.
18. Schrijvers B F, De Vriese A S & Flyvbjery A, From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines, Endocr Rev, 2 (2004) 971.
19. Satchell S C & Tooke J E, What is the mechanism of microalbuminuria in diabetes: A role for the glomerular endothelium?, Diabetologia, 51 (2008) 714.
20. Toyota E, Ogasawara Y, Fujimoto K, Kajita T, Shigeto F, Asana T, Watanabe N & Kajiya F, Global heterogeneity of glomerular volume distribution in early diabetic nephropathy, Kidney Int, 66 (2004) 855.
21. Christiansen N J, Acute effect of insulin on cardiovascular function and noradrenaline uptake and release, Diabetologia, 25 (1983) 377.
22. Mogensen C E, Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas, Diabetologia, 42 (1999) 263.
23. Nobrega M A, Fleming S, Roman R J, Shiozawa H, Schlick N, Lazar J & Jacob H J, Initial characterization of a rat model of diabetic nephropathy, Diabetes, 53 (2004) 735.
24. Kanwar Y S & Farquhar M G, Anionic sites in the glomerular basement membrane: In vivo and In vitro localization to the laminae rarae by cationic probes, J Cell Biol, 81 (1979) 137.
25. Comper W D, Lee A S, Tay M & Adal Y, Anionic charge concentration of rat kidney glomeruli and glomerular basement membrane, Biochem J, 289 (1993) 647.
26. Juretic D, Krajnovic V & Lukac-Bajalo J, Altered distribution of urinary glycosaminoglycans in diabetic subjects, Acta Diabetol, 39 (2002) 123.
27. Harvey S J & Miner J H, Breaking down the barrier: Evidence against a role for heparan sulfate in glomerular permselectivity, J Am Soc Nephrol, 18 (2007) 672.
28. Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowsk M, Siewko K, Nikolajuk A, Kinalska I & Gorska M, Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression, Diabetes Metab Res Rev, 24 (2008) 310.
29. Abrass C K, Peterson C V & Raugi GJ, Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats, Diabetes, 37 (1988) 1695.
30. Cohen M P, Lautenslager G T & Shearman C W, Increased collagen IV excretion in diabetes: A marker of compromised filtration function, Diabetes Care, 124 (2001) 914.
31. Stackhouse S, Miller P L, Park S K & Meyer T W, Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats, Diabetes, 39 (1990) 989.